403
views
0
recommends
+1 Recommend
1 collections
    1
    shares
      scite_
       
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      An Open Access Strategy for the Drug Repurposing Community

      Preprint
      In review
      research-article
        1 ,
      DrugRxiv
      REPO4EU
      Open Science, Open Access, Preprint, Reproducibility, Persistent Identifier, Intellectual Property, FAIR Data, Altmetrics, Open Citations
      Bookmark

            Abstract

            To ensure the widest possible dissemination of research results to the academic community, pharmaceutical industry, patients and to the broader public, the EU-funded drug repurposing project REPO4EU is committed to an Open Science approach. Because Open Science can be interpreted widely, this document lays out the strategy of the project with regard to Open Access publishing, alternative metrics, intellectual property and FAIR data, in line with the goals of the European Commission. The Open Science Strategy forms the theoretical framework for the REPO4EU Open Science publishing portal that will develop into an open hub of research results and communication for the entire drug repurposing community.

            Content

            Author and article information

            Journal
            DrugRxiv
            REPO4EU
            19 July 2023
            Affiliations
            [1 ] ScienceOpen GmbH, Berlin, Germany;
            Author notes
            Author information
            https://orcid.org/0000-0002-2298-2418
            Article
            10.58647/DRUGARXIV.PR000001.v1
            c6c74232-e08a-4f2c-b176-a2ec7cb2bcee

            This work has been published open access under Creative Commons Attribution License CC BY 4.0 , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Conditions, terms of use and publishing policy can be found at www.scienceopen.com .

            History
            : 19 July 2023
            : 20 July 2023
            Funding
            Funded by: funder-id http://dx.doi.org/10.13039/100018696, HORIZON EUROPE Health;
            Award ID: 101057619
            Categories

            Data sharing not applicable to this article as no datasets were generated or analysed during the current study.
            Information & Library science,Pharmacology & Pharmaceutical medicine
            Intellectual Property,Altmetrics,FAIR Data,Persistent Identifier,Reproducibility,Open Citations, Preprint,Open Science,Open Access

            Comments

            Comment on this article